Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Bruker Advances Single-Cell Proteomics and Immunopeptidomics Performance; Unveils New Proteomics Software and Applications for Enhanced Biological Insights at US HUPO
-
ez1095 ACA Software Offers Video Instructions for Upcoming Efile Deadlines
-
Aeva Announces Date for Fourth Quarter and Full Year 2024 Results and Conference Call
-
Volato Begins Bitcoin Mining, Targets Citation CJ Series for First Aviation-Based Crypto Mining Platform
-
Over 2,000 School Support Workers Join Strike Today
-
United Therapeutics Corporation to Present at the TD Cowen 45th Annual Health Care Conference
-
Nektar Announces Clinical Trial Agreement to Evaluate Rezpegaldesleukin in Patients with New Onset Type 1 Diabetes Mellitus
-
KalVista Pharmaceuticals to Present at Upcoming Investor Conferences
-
Newly Formed Stronvar Aerospace Announces Acquisition of Electro Methods Inc., Investment from Blackstone
-
OXIO Appoints Robb Robinson as SVP of Sales and Channels to Fuel Expansion Across the U.S.
-
WeRide’s Latest Robotaxi GXR to Start First Fully Unmanned Commercial Operations in Beijing
-
BirdseyePost Unveils Penny©, a Fully Autonomous AI Agent for Scalable, Data-Driven Marketing Across Print and Digital
-
Cullinan Therapeutics to Participate in Upcoming Investor Conferences
-
iHerb Surpasses $2.4 Billion in Sales, Solidifying Leadership in Global Health and Wellness
-
Axsome Therapeutics Announces SYMBRAVO® (meloxicam and rizatriptan) Achieves Primary Endpoint in the EMERGE Phase 3 Trial in Migraine Patients Experiencing Inadequate Response to Oral CGRP Inhibitors
-
Rapport Therapeutics to Participate in Upcoming Investor Conferences
-
Syndax to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call and Webcast on March 3, 2025
-
Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer
-
Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives
-
OTC Markets Group Welcomes ZRCN Inc. to OTCQX
-
Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference
-
Beam Therapeutics to Participate in Upcoming March 2025 Investor Conferences
-
PyroGenesis Signs $2.4 Million Contract with Norsk Hydro ASA
-
Latus Bio Announces Data Presentations in Support of its Preclinical Huntington’s Disease Gene Therapy Program
-
OTC Markets Group Welcomes Anaergia Inc. to OTCQX
-
CareCloud to Announce Fourth Quarter and Full Year 2024 Results on March 13, 2025
-
C4 Therapeutics to Participate in Upcoming March Investor Conferences
-
Entrada Therapeutics Announces FDA Removal of Clinical Hold on ENTR-601-44
-
Fractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 3, 2025
-
Avalo Therapeutics to Participate in Upcoming Investor Conferences
-
Signify share repurchase period update
-
U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Supplemental Biologics License Application for Opdivo® Plus Yervoy® for Patients with Unresectable or Metastatic Microsatellite Ins
-
Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference
-
Kaspi.kz 4Q and FY 2024 Financial Results
-
MAG Provides Exploration Update and Outlook for Larder and Deer Trail Projects
-
Wallbox Announces $10 Million Investment
-
UnitedHealth Group Board Authorizes Payment of Quarterly Dividend
-
Bright Minds Biosciences to Participate at Three Healthcare Conferences in March
-
IFS appoints Matt Breslin as President, North America
-
Target Hospitality Provides Update on Pecos Children's Center Contract
-
Canada Nickel Closes Previously Announced Definitive Agreement for Creation of 'ExploreCo' with Spin-out of Eastern Exploration Properties
-
Gold Royalty Announces Amended and Upsized Revolving Credit Facility to Maximum $75 Million at Reduced Interest Cost and Extended Maturity and Provides an Update on Selected Portfolio Assets
-
Merck to Participate in the TD Cowen 45th Annual Health Care Conference
-
Brown & Brown, Inc. names Stephen P. Hearn as executive vice president and chief operating officer
-
BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025
-
Brown & Brown, Inc. names Stephen P. Hearn as executive vice president and chief operating officer
-
Buyback of Class B shares in Essity during week 8, 2025
-
Studio City Announces Earnings Release Date
-
Melco Announces Earnings Release Date
-
Net Asset Value(s)
